Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,309 | -3,485 | -22,727 | -8,368 | -5,118 |
| Depreciation Amortization | 751 | 1,443 | -1,569 | -1,525 | 1,489 |
| Income taxes - deferred | N/A | N/A | 831 | N/A | N/A |
| Accounts receivable | -1,683 | 1,856 | 592 | 120 | -1,023 |
| Other Working Capital | -2,514 | 58 | 604 | 2,500 | 2,402 |
| Other Operating Activity | 4,187 | -2,454 | 8,589 | -1,308 | -1,879 |
| Operating Cash Flow | $-14,568 | $-2,582 | $-13,680 | $-8,581 | $-4,129 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,161 | -722 | -11 | -29 | 6 |
| Net Acquisitions | 26,037 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -609 | N/A |
| Other Investing Activity | 207 | -8 | -1 | -629 | 50 |
| Investing Cash Flow | $25,083 | $-730 | $-12 | $-658 | $56 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 13 | N/A | 54,287 | 23,500 |
| Other Financing Activity | -588 | -370 | -118 | -3,250 | -3,032 |
| Financing Cash Flow | $-588 | $-357 | $-118 | $51,037 | $20,468 |
| Exchange Rate Effect | -212 | 157 | -879 | -769 | 38 |
| Beginning Cash Position | 6,678 | 10,190 | 65,300 | 24,271 | 7,838 |
| End Cash Position | 16,393 | 6,678 | 50,611 | 65,300 | 24,271 |
| Net Cash Flow | $9,715 | $-3,512 | $-14,689 | $41,029 | $16,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,568 | -2,582 | -13,680 | -8,581 | -4,129 |
| Capital Expenditure | -1,161 | -722 | -11 | -30 | N/A |
| Free Cash Flow | -15,729 | -3,304 | -13,691 | -8,611 | -4,129 |